These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13102579)

  • 41. [Practical value of the complement fixation reaction in trypanosomiasis gambiense. II. Complement fixation reaction in a case of relapse after medicinal treatment].
    EVENS F; SCHOENAERS F; NEUJEAN G; KAECKENBEEK A; STYNS J
    Ann Soc Belg Med Trop (1920); 1953 Oct; 33(5):389-402. PubMed ID: 13139073
    [No Abstract]   [Full Text] [Related]  

  • 42. The first case of highly drug resistant African sleeping sickness treated in the United States of America.
    FRIEDHEIM EA
    Am J Trop Med Hyg; 1953 Jul; 2(4):634-6. PubMed ID: 13065630
    [No Abstract]   [Full Text] [Related]  

  • 43. Msb and MsbB in the treatment of sleeping sickness due to infection with Trypanosoma gambiense.
    FRIEDHEIM EA
    Ann Trop Med Parasitol; 1953 Dec; 47(4):350-60. PubMed ID: 13125266
    [No Abstract]   [Full Text] [Related]  

  • 44. Nitrofurazone in the treatment of sleeping sickness due to Trypanosoma rhodesiense.
    APTED FI
    Trans R Soc Trop Med Hyg; 1960 May; 54():225-8. PubMed ID: 13793989
    [No Abstract]   [Full Text] [Related]  

  • 45. [Metronidazole in a case of sleeping sickness caused by Trypanosoma rhodesiense].
    ADRIAENSSENS K
    Ann Soc Belg Med Trop (1920); 1961 Oct; 41():393-5. PubMed ID: 13859472
    [No Abstract]   [Full Text] [Related]  

  • 46. Cell inclusions and the epidemiology of Rhodesian sleeping sickness.
    ORMEROD WE
    Trans R Soc Trop Med Hyg; 1960 Jul; 54():299-300. PubMed ID: 14429095
    [No Abstract]   [Full Text] [Related]  

  • 47. [The use of trepolysin (4000 M) or m-amino-p-hydroxyphenylarsenoxy camphorsulfonate in the treatment of sleeping sickness].
    CECCALDI J; TRINQUIER E; ARNOULT H
    Bull Soc Pathol Exot Filiales; 1953; 46(1):87-95. PubMed ID: 13066958
    [No Abstract]   [Full Text] [Related]  

  • 48. Aspects of medical control of Rhodesian sleeping sickness in Tanganyika.
    LAUFER I
    East Afr Med J; 1955 Dec; 32(12):465-80. PubMed ID: 13285421
    [No Abstract]   [Full Text] [Related]  

  • 49. The haemolytic effect of primaquine and nitrofurazone in cases of sleeping sickness with the haemolytic trait.
    ROBERTSON DH
    Ann Trop Med Parasitol; 1961 Oct; 55():278-86. PubMed ID: 14492811
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of experimental trypanosomiasis caused by Trypanosoma brucei brucei in sheep: study of the minimum active dose of melarsoprol].
    Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):548-54. PubMed ID: 3197250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trypanosomiasis in a rural hospital in Tanzania. A retrospective study of its management and the results of treatment.
    Veeken HJ; Ebeling MC; Dolmans WM
    Trop Geogr Med; 1989 Apr; 41(2):113-7. PubMed ID: 2763355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Melarsoprol Resistance in African Trypanosomiasis.
    Fairlamb AH; Horn D
    Trends Parasitol; 2018 Jun; 34(6):481-492. PubMed ID: 29705579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy.
    Haller L; Adams H; Merouze F; Dago A
    Am J Trop Med Hyg; 1986 Jan; 35(1):94-9. PubMed ID: 3946740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of human African trypanosomiasis].
    Dumas M; Breton JC; Pestre-Alexandre M; Nicolas JA; Catanzano G
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):622-7. PubMed ID: 6673855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [African trypanosomiasis at the Claude-Bernard Hospital (diagnostic circumstances and therapeutic problems)].
    Coulaud JP; Vachon F; Lebigot P; Lagarde P; Pasticier A; Saimot G
    Ann Med Interne (Paris); 1975; 126(8-9):671-6. PubMed ID: 1217776
    [No Abstract]   [Full Text] [Related]  

  • 56. A TRIAL OF MEL W IN THE TREATMENT OF TRYPANOSOMA RHODESIENSE SLEEPING SICKNESS.
    ROBERTSON DH
    Trans R Soc Trop Med Hyg; 1963 Jul; 57():274-89. PubMed ID: 14047025
    [No Abstract]   [Full Text] [Related]  

  • 57. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
    Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ
    Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Furaltadone in human Rhodesian sleeping sickness, Report of the first three cases.
    ADRIAENSSENS K
    Ann Soc Belg Med Trop (1920); 1960 Oct; 40():715-23. PubMed ID: 13681531
    [No Abstract]   [Full Text] [Related]  

  • 59. Trypanosoma brucei rhodesiense: effect of immunosuppression on the efficacy of melarsoprol treatment of infected mice.
    Frommel TO
    Exp Parasitol; 1988 Dec; 67(2):364-6. PubMed ID: 3191962
    [No Abstract]   [Full Text] [Related]  

  • 60. MEL W: FINAL REPORT ON A FIELD TRIAL IN THE TREATMENT OF TRYPANOSOMA GAMBIENSE SLEEPING SICKNESS.
    WATSON HJ
    Trans R Soc Trop Med Hyg; 1965 Mar; 59():163-70. PubMed ID: 14300534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.